Buze Chen

Xuzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.

Signaling intact membrane-bound IL-15 enables potent anti-tumor activity and safety of CAR-NK cells.

Journal: Frontiers in immunology
Published: July 02, 2025

Role of TPD52 in Endometrial Cancer: Impact on EMT and the PI3K/AKT and ERK/MAPK Signaling.

Role of TPD52 in Endometrial Cancer: Impact on EMT and the PI3K/AKT and ERK/MAPK Signaling.

Journal: Protein and peptide letters
Published: May 10, 2025

Anticancer activity of Momordica charantia-derived extracellular vesicle-like particle against cervical cancer.

Anticancer activity of Momordica charantia-derived extracellular vesicle-like particle against cervical cancer.

Journal: Tissue & cell
Published: October 13, 2024

Is early vaginal sexual behavior associated with the occurrence of pelvic inflammatory disease: An analysis based on NHANES.

Is early vaginal sexual behavior associated with the occurrence of pelvic inflammatory disease: An analysis based on NHANES.

Journal: Medicine
Published: September 02, 2024

FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight.

FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight.

Journal: Current medicinal chemistry
Published: July 27, 2024

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway.

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway.

Journal: Frontiers in pharmacology
Published: May 03, 2024

CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.

CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.

Journal: Oncogene
Published: March 19, 2024

Author Correction: Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.

Author Correction: Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.

Journal: Scientific reports
Published: October 17, 2023

TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification.

TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification.

Journal: Recent patents on anti-cancer drug discovery
Published: June 15, 2023

Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.

Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer.

Journal: Scientific reports
Published: June 07, 2023

TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis.

TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis.

Journal: Current molecular medicine
Published: May 01, 2023

PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.

PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.

Journal: PloS one
Published: January 21, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026